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primers. The reaction started at 63°C (annealing temperature), which is a
degree little bit higher than Tm of the primer-template complexes. The
annealing temperature ofeach subsequent two cycles was decreased at 1°C
less than the preceding cycles, and this procedure was continued from 63°C
down to 56°C. The reaction ended with 24 cycles at 56°C eventually.
Topic 11 - Pharmacoeconomics
0:11 - Economical issues
IMo0411 Temporal and regional variations in antimicrobial
use in the primary health care sector, Denmark, 1994-1998
D. L. Monnetl , T. L. Soerensent, H. L.johansen2
1Dept. ofResearch and Development, Div. ofMicrobiology. Statens Serum
Instilul; 2Danish Medicines Agency, Copenhagen, Denmark
Objective: This study was performed as part of the Danish Integrated
Antimicrobial Resistance Monitoring and Surveillance Programme
(OANMAP) to examine temporal and regional variations of antimicrobial
use in primary health care (PHC) in the 16 Danish counties.
Methods: Since 1994, data on each prescription redeemed at a PHC
pharmacy are transmitted electronically to the Danish Medicines Agency
and then converted into Defined Daily Doses (DDD). Population data were
obtained from Statistics Denmark.
Results: Nationwide, the level of antimicrobial use (ATC group jOl) in
PHC was 12.7 (1994),12.7 (1995),11.3 (1996),11.3 (1997), and 11.9 DDOI
1,000 inhabitant-days (1998). The decrease between 1995 and 1996 was
related to a reduction in the subsidization of almost all subsidized anti-
microbials, whereas the increase observed in 1998 has been attributed to
excessive macrolide use after announcement of a Mycoplasma pneumoniae
outbreak. Both events had an effect whatever the county; however, there
were large variations among counties for the level ofantimicrobial use. For
example, antimicrobial use Was almost always the lowest in Aarhus county
with 10.4 (1994),10.4 (1995), 9.1 (1996),9.1 (1997) and 9.6 ODD/l,OOOinh.-
days (1998), and the highest in Ribe county with 14.7 (1994), 13.9 (1995),
12.7 (1996), 12.8 (1997) and 13.2 ODDll,OOO inh.-days (1998). Additionally,
counties situated around Copenhagen generally had a high level of anti-
microbial use.
Conclusion: These results illustrate the importance ofmonitoring variations
of antimicrobial use during time and at the regional level. Hypotheses to
explain differences among counties are presently being formulated and
tested.
IMo042IOutcomes of treatment of intra-abdominal
infections
P. Daveyl, G. Libby·, K. Hunter!,). Broornhall', O. Steinke·, D. Yin2
1MEMO, Dundee, United Kingdom; 2Merck & Co , United States
Objectives: To relate hospital costs to the outcome ofantibiotic treatment
for community-acquired intra-abdominal infection.
Methods: Patients were identified from hospital discharges at three hospitals
for 1993 to 1997 by ICD9 codes: 567 (peritonitis); 540 (appendicitis); 531-
534 (gastric, duodenal, peptic or gastrojejunal ulcers with perforation).
Medical records were obtained to validate the diagnosis, obtain details of
antibiotic therapy and its outcome. Total hospital costs were calculated from
duration of stay within specific care settings (ICU, surgery, rehabilitation,
etc). Appropriate empirical therapy was defined from the results ofin-vitro
sensitivity tests and compliance with local antibiotic policies.
Results: Of528 potential cases, 278 (53%) had confirmed, intra-abdominal
infections without exclusion criteria and 212 had complete data. Patients
with unsuccessful treatment (additional antibiotic or surgical treatment or
died ofinfection) had significantly increased hospital stay and costs: Median
Hospital Stay: 8 days (range 2-76) with Successful Outcome (n = 176):
versus 13 days (range 2-84) with Unsuccessful Outcome (n = 36): p =
0.0023, Wilcoxon Test
Median Hospital Cost: £2544 with Successful Outcome (range £636 to
24,661) versus £4133 with Unsuccessful Outcome (range £636 to 16,363»;
p = 0.0005, Wilcoxon Test
Unsuccessful Outcome was more likely to occur in patients who received
inappropriate empirical antibacterial treatment (OR 1.82; 95% CI 0.8 to 4.2)
bur the difference was not statistically significant (p = 0.156).
Results: The yields of the specific products have increased, and non-specific
bands have been eliminated with TO-PCR technique
Conclusions: The use of thermal cycler programming using of TO-PCR
technique, which represents a fundamentally different approach to PCR
optimization, induces specificity and maximal productivity.
Conclusions: Unsuccessful antibiotic treatment was associated with
increased hospital costs and with inappropriate empirical treatment.
[Mo043!1s community antibiotic treatment associated with
better outcome of hospitalisation for LRTI1
D. Stcinkc, P. Donnan. T. MacDonald, P. Davey
MEMO, Dundee, United IGngdom
Objectives: To test the hypothesis that prior community antibiotic treat-
ment of lower respiratory tract infection (LRTI) is associated with lower
mortality and shorter length of hospital stay.
Methods: Patients with hospital discharge codes including LRTI or chronic
obstructive airways disease (COAD) were identified at three acute hospitals
from discharge diagnoses for 1993 to 1995. Patients with episodes starting >
48 h after admission were excluded as having nosocomial pneumonia. Prior
community antibiotic treatment was defined as any treatment in the 28 days
before hospitalisation.
Results: There were 1285 patients with LRTI alone and 1603 with COAD
of whom 366 also had LRTI. Antibiotic treatment occurred before hospi-
talisation in 35% of patients with LRTI alone and 41 % of patients with
COAD. Patients with LRTI alone who received community antibiotics
were less likely to die in the 50 days after admission: relative risk 0.83 (0.69-
1.00) adjusted for age, sex and social deprivation. There was no difference in
50 day mortality between COAD patients who did or did not receive
community antibiotics. Length of stay was not different for patients who
received community antibiotics, either in the entire cohort (p = 0.25) or in
the 832 patients who were discharged alive (p = 0.81).
Condusion: Community antibiotic treatment is associated with reduced 50
day mortality for patients admitted with LRTI, but not COAD, and is not
associated with reduced length of hospital stay for either diagnosis.
IMo0441 Practice variations among Italian paediatricians in
the management of lower respiratory tract infections
S. Esposito, F. Blasi 1, L. Fagetti', C. Arosio I, P. TarsiaI, S. Bosis, L.
Allegra!, N. Principi
Paediatr DepllV, L. Sacco Hosp, Univ Mildtl; l lnst Resp Dis, IRCCS
Maggiore Hosp, Univ Mildtl, Italy
In order to evaluate the antibiotic-prescribing practices of Italian paedia-
tricians in lower respiratory tract infections, data from 613 children aged 2-
14 yrs (310 males; mean age, 5.16 ± 3.06 yrs) hospitalized for acute
bronchitis, wheezing or pneumonia in 21 Italian municipalities were
analyzed. A total of324 patients (52.8%) were 2 to 4 yrs and 289 (47.2%)
~ 5 yrs. Patients were classified according to the following diagnoses: acute
bronchitis, 113 (18.4%); wheezing, 82 (13.4%); pneumonia, 418 (68.2%).
Antibiotics were prescribed to 92.1 % of children: 85% with acute bron-
chitis, 72.0% with wheezing and 97.9% with pneumonia. The Table shows
the main therapeutic categories for different clinical presentation and age
group.
Acute bronchitis Wheezing Pneumonia
('Yo) ('Yo) ('Yo)
Thenpy 2-4yn ~5yn 2-4yn ~5yrs 2--4 yrs ~5yrs
Cephalosporin. 19.3 9.8 11.3 20.6 SO.7 25.8
Macrolides 40.3 43.1 41.3 27.5 14.7 25.9
No antibiotic 9.6 21.5 22.6 37.9 1.9 2.3
If the evidence-based guidelines had been followed, antibiotics should
have been withheld from most of the patients with acute bronchitis and
wheezing. This study shows a high frequency ofinappropriate antibiotic use
in the treatment of lower respiratory tract infections among paediatrie
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population in Italy. Reducing unnecessary antibiotic we in children has
become a public health priority in our country. In order to limit the risk of
emerging resistant bacteria and contain costs. it is urgent to educate
paediatricians in the rational use of antibiotics.
IMo04SI Measuring the quality of an outpatient and home
intravenous antibiotic therapy (OHPAl) programme: Use of an
Intematlonal Registry
D. Nathwani,J. Morrison, G. Barlow, A. Tice
Infection & Immunodeficiency Unit, Tayside University Hospitals Trust,
Dundee, United Kingdom; Tachoma, USA
Objectives: 1) To describe a method for continuos quality measurement ofa
clinical programme providing a regional OHPAT service. This system
which has now been operational for more than 20 months. The integrated
care pathway (ICP) used on all patients incorporates a number of key
measures of quality-patient clinical outcome and satisfaction, laboratory
(microbiology) outcome and economic outcome. Some of the generic data
are currently being incorporated into an International OPAT Registry
which aims 2) to provide an international database for determining the most
clinically and cost-effective regimens based on measurable outcome data
and. provide benchmark outcomes for providers.
Results: Number of patients treated: 183; Principle diagnosis: Skin& soft
tissue infections 51.5%. bone and joint infections 22.8%. Endocarditis;
others. Home (self administered) v Outpatient (nurse administered): 40%
v 57%. Clinical outcome: Cure/improving 94%, No Change 2%. Worse 4%.
Microbiological Outcome: 20% Culture positive-one patient had persisting
organism post-therapy. Drug related adverse reactions: 6%. Unscheduled
hospital readmission: 7.5%; Economic outcome: 2300 inpatient bed days saved;
additional cost of drugs < £12/day. Patient satiifaction: High (specific data
will be presented). Collection of such outcome measures locally and
internationally should be an integral part of an OHPAT quality assurance
programme and the International Registry will allow benchmarking and
comparisons of etfectiveness.
IMo046IResource use and cost of care for patients
hospitalized with Community Acquired Pneumonia (CAP)
W. Russell, R. Segal. F. Wang. D. Yin, T. Johns, J. Orrick
University ofFlorida, Pharmacy Health Care Administration, Gainesville
Florido 32610, United States
Objective: To examine inpatient resource use and cost of care for patients
with CAP in real-world practice settings.
Methods: A multicenter observational study was conducted in Florida
between July 1997 and October 1999. Hospitalized adult patients (> = 18
years) started on antimicrobial therapy for suspected or confirmed commu-
nity-acquired pneumonia were enrolled in the study. Exclusion criteria were
immunosuppression, cystic fibrosis and hospitalization in prior 2 weeks.
Information on patient demographic characteristics. risk class. resource use.
economic data and outcome measures were collected.
Results: 69 patients were enrolled in the study. Average age was 62.8 ± 17.2
(range 23-92); 58.9% were female. The number (%) of patients in risk
classes I-V according to Fine et al. (NEJM 1997) were 9 (13%). 24 (34.8%).
19 (27.5%), 14 (20.3%) and 3 (4.3%) respectively. Average time from ER
admission to lst dose ofantibiotic was 7.5 hours. Most frequently prescribed
antibiotics included azithromycin (29.9%), ceftriaxone (16.8%) and levo-
ftoxacin (16.4%). 40 patients received a beta-lactam/macrolide or macrolide/
quinolone. Average length of antibiotic therapy was 5.6 ± 3.2 days.
Average hospitalization cost excluding physician cost was S4,024, with
hospital room/board accounting for the largest percentage (85%), followed
by laboratory (8%), drugs (4%), radiology (2%) and respiratory (1 %). 66%
of patients received antimicrobial therapy consistent with Bartlett and
Mundy guideline (NEJM 1995) and these patients incurred lower costs
(S3,363/patient) compared to patients receiving therapy inconsistent with
guideline ($4,986/patient).
Conclusion: Understanding the processes of care in real-world practice
settings is important for improving the quality and cost-effectiveness of
care for hospital patients with CAP.
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IMoP230IUse and cost of antibiotics in a long term care
facility versus community teaching hospital in Northern Israel
V. Rozenfeld.J. Ben Israel, R. Raz l
Shoham Geriatric Center, Pardes Hanna; 'Haemek Medical Center, AjUla,
Israel
objectives: To evaluate the use and cost ofantibiotics in a Long Term Care
Facility (LTCF) with 970 beds and to compare them with a Community
Teaching Hospital (CTH) with -440 beds.
Methods: A three-point prevalence survey was performed between 7/97-6/
98 in both hospitals in order to evaluate the number of pts receiving
antibiotics. The use of antibiotics was evaluated by the Defined Daily
Dose (DOD) 1,000 hospitalization days (hd) and the cost in US S/I,OOO hd.
Results: 5.9% of the LTCF inhabitants and 24.7% of the CTH in pts
received antibiotics during the three-point prevalence survey. In the LTCF
29% of the total antibiotics prescribed were administered intravenously in
contrast to 53% in theCTH. The total DDD/l,OOOhdin the LTCF was 87.4
and in the CTH 661, with the cost of the antibiotics being 257 USS/l.000 hd
in the LTCF and 4436 USS/l,OOO hd in the CTH.
conduslons: The use and cost of antibiotic.. in a CTH is considered higher
than in a LTCF. Even though this was the expected conclusion. this is the
first study to compare antibiotic "consumption" between a CTH and a
LTCF.
IMoP231I AdHOC: Advisory group on home-based and
outpatient care. Results of a survey of OHPAT practice in the EU
and beyond
D. Nathwanil,J. -J. Zambrowski2, I. HardingJ
'Tayside University Hospital Trust, Dundee, United Kingdom; 2Hopital
Bichat, Paris, France; JMicron Research, Cambs, United Kingdom
Objectives: An advisory group has been formed to facilitate and promote
home-based and outpatient care, comprising members from EU and other
non-US countries. We report the results ofa survey ofoutpatient and home
parenteral antibiotic therapy (OH PAT) amongst members of the group.
Methods: Members completed a questionnaire on perceptions and actual
OHPAT practice in their countries.
Results: Group members from 13 countries participated, 6 ofwhom (46%)
already run an OHPAT service. OHPAT was both hospital and commu-
nity-based in 10 (77%) countries. The medical specialties most involved
were infectious diseases (all countries). haematology, general practice and
orthopaedics. Use ofOHPAT was widespread in some countries (eg. Italy)
but less well accepted in others. mostly because of financial constraints.
Formal survey data of OHPAT we exist in only 4 countries of the 13
reported here (Netherlands, UK, Italy, Brazil). OHPAT services were
controlled mostly by individuals or institutions, rather than by government
or reimbursement/insurance agencies. All participants considered that
OHPAT would increase during the next five years, given changes in funding
or reimbursement systems. The main barriers to acceptance were: lack of
organisation, lack of clinical trial data and funding issues.
Condusions: OHPAT is widespread outside the USA, but barriers exist to
its acceptance and expansion elsewhere. In our current cost-conscious
healthcare environment. it is important to find new ways of delivering
care which are Cost-effective and improve quality of life for patients and
carers. The group aims to provide a forum for developing generic and local
guidance for OHPAT and hopes to collaborate with the ENIS Group with a
view to promoting OHPAT in Europe and beyond.
IMOP232! Pharmacoeconomic evaluation of antibiotics in
acute sinusitis in adults
O. Karpov, A. Zaytsev, YU. Ignatov
Institute ofPharmacology, Saint-Petersburg, Russian Federation
Objectives: A number ofantimicrobial agents are effective in the treatment
ofacute sinusitis. Economic evaluation is necessary for best practice recom-
mendations.
Methods: The economic outcomes of azithromycin (AZ), midecamycin
(Me). co-amoxic1av (CA) and cefadroxil (CF) treatment were studied in
randomised investigation among 160 adults with confirmation of acute
sinusitis. 50 patients received AZ at 500 mg once a day during 3 days. 30 -
